Cargando…
A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer
BACKGROUND: There is considerable variation in the staging of lymph nodes (LNs) as part of tumor, node, metastasis (TNM) staging of non-small cell lung cancer (NSCLC). A new dissection and pathological examination standard for hilar and intrapulmonary LNs needs to be established for patients with ea...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743510/ https://www.ncbi.nlm.nih.gov/pubmed/35070763 http://dx.doi.org/10.21037/tlcr-21-959 |
_version_ | 1784629917282992128 |
---|---|
author | Zhu, Zhihua Mei, Weijian Song, Zhengbo Jiao, Wenjie Huang, Qinghua Zhu, Lianxin An, Chaolun Shi, Jianguang Wang, Wenxian Yu, Guiping Sun, Pingli Zhang, Yinbin Shen, Jianfei Song, Yong Gilbert, Sebastien Ruetzler, Kurt Villamizar, Nestor R. Xu, Chunwei Qian, Jun Yao, Wang Yang, Han |
author_facet | Zhu, Zhihua Mei, Weijian Song, Zhengbo Jiao, Wenjie Huang, Qinghua Zhu, Lianxin An, Chaolun Shi, Jianguang Wang, Wenxian Yu, Guiping Sun, Pingli Zhang, Yinbin Shen, Jianfei Song, Yong Gilbert, Sebastien Ruetzler, Kurt Villamizar, Nestor R. Xu, Chunwei Qian, Jun Yao, Wang Yang, Han |
author_sort | Zhu, Zhihua |
collection | PubMed |
description | BACKGROUND: There is considerable variation in the staging of lymph nodes (LNs) as part of tumor, node, metastasis (TNM) staging of non-small cell lung cancer (NSCLC). A new dissection and pathological examination standard for hilar and intrapulmonary LNs needs to be established for patients with early-stage T1–3N0M0 NSCLC. METHODS: This study involved 3,002 patients with T1–3N0M0 NSCLC who underwent radical lobectomy or total pneumonectomy in the thoracic departments of 11 Chinese institutions between January 1999 and October 2013. The Cox model was applied for univariate and multivariate analyses in the examination of station 10, 11 LN and station 12, 13, 14 LN. A hilar and intrapulmonary standard (HI standard) was then established based on univariate and multiple-factor analyses conducted using the Cox model. RESULTS: Among the 3,002 patients enrolled in the study, 2,609 underwent at least one examination of station 10, 11 LN (A1), while 393 did not undergo examination of station 10, 11 LN (A0). The A0 and A1 groups had 5-year survival rates of 76% and 80%, respectively (P=0.018). Further, 1,764 patients underwent at least one examination of station 12, 13, 14 LN (B1), while 1,238 patients did not (B0). The B0 and B1 groups had 5-year survival rates of 77% and 82%, respectively (P=0.008). In total, 1,269 patients attained the HI standard (C1), and 1,733 did not (C0). The C0 and C1 groups had 5-year survival rates of 77% and 83%, respectively (P<0.001). CONCLUSIONS: The HI standard can improve both the prognosis and survival rates of patients with T1–3N0M0 NSCLC. This will provide important guidance for pulmonary LN dissection and pathological examination in NSCLC cases. |
format | Online Article Text |
id | pubmed-8743510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87435102022-01-21 A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer Zhu, Zhihua Mei, Weijian Song, Zhengbo Jiao, Wenjie Huang, Qinghua Zhu, Lianxin An, Chaolun Shi, Jianguang Wang, Wenxian Yu, Guiping Sun, Pingli Zhang, Yinbin Shen, Jianfei Song, Yong Gilbert, Sebastien Ruetzler, Kurt Villamizar, Nestor R. Xu, Chunwei Qian, Jun Yao, Wang Yang, Han Transl Lung Cancer Res Original Article BACKGROUND: There is considerable variation in the staging of lymph nodes (LNs) as part of tumor, node, metastasis (TNM) staging of non-small cell lung cancer (NSCLC). A new dissection and pathological examination standard for hilar and intrapulmonary LNs needs to be established for patients with early-stage T1–3N0M0 NSCLC. METHODS: This study involved 3,002 patients with T1–3N0M0 NSCLC who underwent radical lobectomy or total pneumonectomy in the thoracic departments of 11 Chinese institutions between January 1999 and October 2013. The Cox model was applied for univariate and multivariate analyses in the examination of station 10, 11 LN and station 12, 13, 14 LN. A hilar and intrapulmonary standard (HI standard) was then established based on univariate and multiple-factor analyses conducted using the Cox model. RESULTS: Among the 3,002 patients enrolled in the study, 2,609 underwent at least one examination of station 10, 11 LN (A1), while 393 did not undergo examination of station 10, 11 LN (A0). The A0 and A1 groups had 5-year survival rates of 76% and 80%, respectively (P=0.018). Further, 1,764 patients underwent at least one examination of station 12, 13, 14 LN (B1), while 1,238 patients did not (B0). The B0 and B1 groups had 5-year survival rates of 77% and 82%, respectively (P=0.008). In total, 1,269 patients attained the HI standard (C1), and 1,733 did not (C0). The C0 and C1 groups had 5-year survival rates of 77% and 83%, respectively (P<0.001). CONCLUSIONS: The HI standard can improve both the prognosis and survival rates of patients with T1–3N0M0 NSCLC. This will provide important guidance for pulmonary LN dissection and pathological examination in NSCLC cases. AME Publishing Company 2021-12 /pmc/articles/PMC8743510/ /pubmed/35070763 http://dx.doi.org/10.21037/tlcr-21-959 Text en 2021 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Zhu, Zhihua Mei, Weijian Song, Zhengbo Jiao, Wenjie Huang, Qinghua Zhu, Lianxin An, Chaolun Shi, Jianguang Wang, Wenxian Yu, Guiping Sun, Pingli Zhang, Yinbin Shen, Jianfei Song, Yong Gilbert, Sebastien Ruetzler, Kurt Villamizar, Nestor R. Xu, Chunwei Qian, Jun Yao, Wang Yang, Han A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer |
title | A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer |
title_full | A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer |
title_fullStr | A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer |
title_full_unstemmed | A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer |
title_short | A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer |
title_sort | standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743510/ https://www.ncbi.nlm.nih.gov/pubmed/35070763 http://dx.doi.org/10.21037/tlcr-21-959 |
work_keys_str_mv | AT zhuzhihua astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT meiweijian astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT songzhengbo astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT jiaowenjie astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT huangqinghua astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT zhulianxin astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT anchaolun astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT shijianguang astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT wangwenxian astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT yuguiping astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT sunpingli astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT zhangyinbin astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT shenjianfei astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT songyong astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT gilbertsebastien astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT ruetzlerkurt astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT villamizarnestorr astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT xuchunwei astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT qianjun astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT yaowang astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT yanghan astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT astandardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT zhuzhihua standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT meiweijian standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT songzhengbo standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT jiaowenjie standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT huangqinghua standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT zhulianxin standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT anchaolun standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT shijianguang standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT wangwenxian standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT yuguiping standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT sunpingli standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT zhangyinbin standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT shenjianfei standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT songyong standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT gilbertsebastien standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT ruetzlerkurt standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT villamizarnestorr standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT xuchunwei standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT qianjun standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT yaowang standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT yanghan standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer AT standardforhilarandintrapulmonarylymphnodedissectionandpathologicalexaminationinearlynonsmallcelllungcancer |